First monkeys, and then us? Human cloning must stay off limits
By Marcy Darnovsky,
New Scientist
| 01. 24. 2018
Remember the human cloning controversies of the early 2000s? One reason they faded was that scientists were unable to clone non-human primates. Now that researchers have produced two cloned monkeys, we should brace ourselves for a rerun of arguments in favour of human clones. But human reproductive cloning would be every bit as misguided and dangerous now as it was then.
As long ago as 1971, James Watson of double helix fame warned in The Atlantic about the prospect of “Moving Toward the Clonal Man”. He later changed his mind and began promoting human reproductive cloning, as well as suggesting that human germline modification could tackle stupidity and ensure all women are “pretty”.
In 1997, headlines announced that scientists in the UK had created what had long been considered biologically impossible: a cloned mammal, a sheep dubbed “Dolly”. Debate about creating human clones immediately followed. Time, for example, put Dolly on its cover the following month and posed the question: “Will There Ever Be Another You?”
A few mavericks claimed to be on the verge...
Related Articles
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...